Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IGBA Urges WIPO To Revoke Patent Database Support

Points To Unverified Information In Originator-Backed Pat-INFORMED Database

Executive Summary

The International Generic and Biosimilar Medicines Association has urged the World Intellectual Property Organization to withdraw its support for a global database of pharmaceutical patent information. The Pat-INFORMED database – which is comprised of intellectual-property information provided by originators – contains unverified data and lacks appropriate safeguards, the IGBA contends.

You may also be interested in...

Sboul Is Appointed IGBA Chair

Hanan Sboul, secretary general of the Jordanian Association of Pharmaceutical Manufacturers, has been named as chair of the International Generic and Biosimilar medicines Association. She takes over from Jim Keon, president of the Canadian Generic Pharmaceutical Association.

IGBA Favors WHO System Over Originator Database

In the final of three exclusive interviews, IGBA chair Jim Keon and secretary general Suzette Kox provide the latest update on global issues affecting the off-patent industries, including originator intellectual-property tactics in the form of the WIPO’s and IFPMA’s Pat-INFORMED database.

WIPO Patent Database Is Flawed And Promotes Linkage

An online register of global patent information for medicines launched by the WIPO and brand industry body IFPMA serves as a tool for patent linkage, contains no mechanisms to ensure accuracy, and is inappropriate for a UN agency to endorse, according to the IGBA.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts